Just received this MHRA alert:
Company led medicines recall: Vertical Pharma Resources Ltd T/A IPS Pharma, Levothyroxine Oral Suspension (Various Strengths) [unlicensed medicine], CLMR(23)A/03
IPS Pharma is recalling specific batches of levothyroxine oral suspension from pharmacies and impacted patients due to the concentration of levothyroxine being greater than the amount stated on the label.
From:
Medicines and Healthcare products Regulatory Agency
Published
27 February 2023
gov.uk/drug-device-alerts/c...
This is peculiar as the alert notice states:
Levothyroxine Oral Suspension (Various Strengths) [unlicensed medicine]
IPS Pharma appear to be a specialist importer and do things like supply unlicensed drugs for trials.
If you are affected by this alert, please post so that we can (hopefully) understand more about the circumstances.